Visualization and quantification of disease progression in multiple system atrophy

被引:41
|
作者
Hauser, Till-Karsten
Luft, Andreas
Skalej, Martin
Naegele, Thomas
Kircher, Tilo T. J.
Leube, Dirk T.
Schulz, Joerg B.
机构
[1] Univ Gottingen, Dept Neurodegenerat & Restorat Res, DGF Res Ctr Mol Physiol Brain, Ctr Neuro Med, D-37073 Gottingen, Germany
[2] Univ Tubingen, Ctr Neurol, Dept Gen Neurol, Tubingen, Germany
[3] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany
[4] Univ Tubingen, Dept Neuroradiol, Tubingen, Germany
[5] Univ Magdeburg, Dept Neuroradiol, D-39106 Magdeburg, Germany
[6] RWTH Aachen Univ, Dept Psychiat & Psychotherapy, Aachen, Germany
[7] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany
关键词
multiple system atrophy; ataxia; neurodegenerative disorders; parkinsonian syndromes; MR imaging; voxel-based morphometry;
D O I
10.1002/mds.21032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To visualize and quantify disease progression in multiple system atrophy (MSA) from cerebellar type (MSA-C), we combined two magnetic resonance imaging (MRI) techniques, voxel-based morphometry (VBM) and 3D-based volumetry. Patients suffering from MSA-C (n = 14) were imaged twice with an interval of 2.0 +/- 0.2 years. We first applied VBM to map brain morphology changes between MSA patients and controls and to identify brain areas that showed a significant amount of atrophy. Using 3D-based volumetry, we confirmed that in MSA-C patients, the brainstem including medulla and pons, vermis and cerebellar hemispheres, caudate nucleus and putamen showed significant atrophy compared with controls. Next, we used 3D-based volumetry to analyze the atrophy rates. Atrophy rates in patients with MSA were significantly different from controls for putamen (- 11.4% +/- 2.6%/year), vermis (-12.3% +/- 2.9%/year), and cerebellar hemispheres (-6.6% +/- 1.1%/year). The results show that 3D-based MRI volumetry is a tool that allows the disease progression of MSA to be followed over a time period of 2 years and suggest that it may serve as a surrogate marker in clinical trials to measure disease progression. (C) 2006 Movement Disorder Society.
引用
收藏
页码:1674 / 1681
页数:8
相关论文
共 50 条
  • [1] Visualization and quantification of disease progression in multiple system atrophy
    Hauser, Till K.
    Lufi, Andreas R.
    Skalej, Martin
    Nägele, Thomas
    Kircher, Tilo T.
    Leube, Dirk T.
    Schulz, Jörg B.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S55 - S55
  • [2] Imaging markers of disease progression in multiple system atrophy
    Heim, Beatrice
    Krismer, Florian
    Poewe, Werner
    Seppi, Klaus
    [J]. FUTURE NEUROLOGY, 2019, 14 (03)
  • [3] Progression of brain atrophy in multiple system atrophy
    Brenneis, Christian
    Egger, Karl
    Scherfler, Christoph
    Seppi, Klaus
    Schocke, Michael
    Poewe, Werner
    Wenning, Gregor K.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (02) : 191 - 196
  • [4] Progression of parkinsonism in multiple system atrophy
    Seppi, K
    Yekhlef, F
    Diem, A
    Wolf, EL
    Mueller, J
    Tison, F
    Quinn, NP
    Poewe, W
    Wenning, GK
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 (01) : 91 - 96
  • [5] Progression of parkinsonism in multiple system atrophy
    Klaus Seppi
    Farid Yekhlef
    Anja Diem
    Elisabeth Luginger Wolf
    Joerg Mueller
    François Tison
    Niall P. Quinn
    Werner Poewe
    Gregor K. Wenning
    [J]. Journal of Neurology, 2005, 252 : 91 - 96
  • [6] White Matter Abnormalities Track Disease Progression in Multiple System Atrophy
    Raghavan, Sheelakumari
    Lesnick, Timothy G.
    Castillo, Anna M.
    Reid, Robert I.
    Fought, Angela J.
    Thostenson, Kaely B.
    Johnson Sparrman, Kohl L.
    Gehrking, Tonette L.
    Gehrking, Jade A.
    Sletten, David M.
    Low, Phillip A.
    Singer, Wolfgang
    Vemuri, Prashanthi
    [J]. MOVEMENT DISORDERS CLINICAL PRACTICE, 2024,
  • [7] Disease progression and survival of multiple system atrophy: A prospective French cohort study
    Foubert-Samier, A.
    Pavy-Letraon, A.
    Guillet, F.
    Helmer, C.
    LeGoff, M.
    Tison, F.
    Rascol, F.
    Proust-Lima, C.
    Meissner, W.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S450 - S450
  • [8] Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study
    Foubert-Samier, Alexandra
    Pavy-Le Traon, Anne
    Guillet, Florian
    Le-Goff, Melanie
    Helmer, Catherine
    Tison, Francois
    Rascol, Olivier
    Proust-Lima, Cecile
    Meissner, Wassilios G.
    [J]. NEUROBIOLOGY OF DISEASE, 2020, 139
  • [9] Neurofilament Light Chain Predicts Disease Severity and Progression in Multiple System Atrophy
    Zhang, Lingyu
    Cao, Bei
    Hou, Yanbing
    Gu, Xiaojing
    Wei, Qianqian
    Ou, Ruwei
    Zhao, Bi
    Luo, Chunyan
    Shang, Huifang
    [J]. MOVEMENT DISORDERS, 2022, 37 (02) : 421 - 426
  • [10] Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy
    Krismer, Florian
    Seppi, Klaus
    Wenning, Gregor K.
    Papapetropoulos, Spyridon
    Abler, Victor
    Goebel, Georg
    Schocke, Michael
    Poewe, Werner
    [J]. PARKINSONISM & RELATED DISORDERS, 2019, 58 : 23 - 27